Specificity of four laboratory approaches for cross-sectional HIV incidence determination: Analysis of samples from adults with known nonrecent HIV infection from five African countries

AIDS Research and Human Retroviruses

Volumn 28, Issue 10, 2012, Pages 1177-1183

  Laeyendecker, Oliver ^a,b   Brookmeyer, Ron ^c   Mullis, Caroline E ^b   Donnell, Deborah ^d,e   Lingappa, Jairam ^d,f   Celum, Connie ^d   Baeten, Jared M ^d   Campbell, Mary S ^d   Essex, Max ^g   De Bruyn, Guy ^h   Farquhar, Carey ^d   Quinn, Thomas C ^a,b   Eshleman, Susan H ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BOTSWANA; CD4 LYMPHOCYTE COUNT; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; KENYA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOUTH AFRICA; TANZANIA; UGANDA; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ALGORITHMS; ANTI-HIV AGENTS; BOTSWANA; CD4 LYMPHOCYTE COUNT; FEMALE; HIV ANTIBODIES; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; KENYA; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; TANZANIA; UGANDA; VIRAL LOAD;

EID: 84866706749     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0341     Document Type: Article

References (23)

1. Brookmeyer R: Measuring the HIV/AIDS epidemic: Approaches and challenges. Epidemiol Rev 2010;32:26-37.
2. Murphy G and Parry JV: Assays for the detection of recent infections with human immunodeficiency virus type 1. Euro Surveill 2008;13:pii18966.
3. Busch MP, Pilcher CD, Mastro TD, Kaldor J, Vercauteren G, Rodriguez W, et al.: Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS 2010;24:2763-2771.
4. Dobbs T, Kennedy S, Pau CP, McDougal JS, and Parekh BS: Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 2004;42:2623-2628.
5. Masciotra S, Dobbs T, Candal D, Hanson D, Delaney K, Rudolph D, et al.: Antibody avidity-based assay for identifying recent HIV-1 infections based on Genetic Systems TM 1/2 plus O EIA. 17th Conference on Retroviruses and Opportunistic Infections, Abstract 937. San Francisco, CA, February 16-19, 2010.
6. Parekh BS, Hanson DL, Hargrove J, Branson B, Green T, Dobbs T, et al.: Determination of mean recency period for estimation of HIV type 1 incidence with the BED-Capture EIA in persons infected with diverse subtypes. AIDS Res Hum Retroviruses 2011;27:265-273.
7. UNAIDS Reference Group on Estimates, Modeling, and Projections: Statement on the use of the BED assay for estimation of HIV-1 incidence or epidemic monitoring. Weekly Epidemiol Rec 2006;81:33-40.
8. Barnighausen T, Wallrauch C, Welte A, McWalter TA, Mbizana N, Viljoen J, et al.: HIV incidence in rural South Africa: Comparison of estimates from longitudinal surveillance and cross-sectional cBED assay testing. PLoS One 2008;3:e3640.
9. Karita E, Price M, Hunter E, Chomba E, Allen S, Fei L, et al.: Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 2007;21: 403-408.
10. Marinda ET, Hargrove J, Preiser W, Slabbert H, van Zyl G, Levin J, et al.: Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on anti-retroviral therapy. J Acquir Immune Defic Syndr 2010;53: 496-499.
11. Hladik W, Olara D, Mermin J, Moore D, Were W, Alexander L, and Downing R: Effect of CD4+ T-cell count and anti-retroviral treatment on two serological HIV incidence assays. AIDS Res Hum Retroviruses 2012;28(1):5-99.
12. Hayashida T, Gatanaga H, Tanuma J, and Oka S: Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassay. AIDS Res Hum Retro-viruses 2008;24:495-498.
13. Incidence Assay Critical Path Working Group: More and better information to tackle HIV epidemics: Towards improved HIV incidence assays. PLoS Med 2011;8:e1001045.
14. Braunstein SL, Nash D, Kim AA, Ford K, Mwambarangwe L, Ingabire CM, et al.: Dual testing algorithm of BED-CEIA and AxSYM Avidity Index assays performs best in identifying recent HIV infection in a sample of Rwandan sex workers. PLoS One 2011;6:e18402.
15. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, et al.: Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010;362:427-439.
16. Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, et al.: Use of hormonal contraceptives and risk of HIV-1 transmission: A prospective cohort study. Lancet Infect Dis 2012;12:19-26.
17. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, et al.: Quantitative detection of increasing HIV type 1 antibodies after seroconversion: A simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002;18:295-307.
18. Kim AA, Hallett T, Stover J, Gouws E, Musinguzi J, Mureithi PK, et al.: Estimating HIV incidence among adults in Kenya and Uganda: A systematic comparison of multiple methods. PLoS One 2011;6:e17535.
19. Young CL, Hu DJ, Byers R, Vanichseni S, Young NL, Nelson R, et al.: Evaluation of a sensitive/less sensitive testing algorithm using the bioMerieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand. AIDS Res Hum Retroviruses 2003;19:481-486.
20. Hemelaar J, Gouws E, Ghys PD, and Osmanov S: Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 2011;25:679-689.
21. Owen SM, Yang C, Spira T, Ou CY, Pau CP, Parekh BS, et al.: Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States. J Clin Microbiol 2008;46:1588-1595.
22. Cousins MM, Laeyendecker O, Beauchamp G, Brookmeyer R, Towler WI, Hudelson SE, et al.: Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection. PLoS One 2011;6:e27211.
23. Laeyendecker O, Rothman RE, Henson C, Horne BJ, Ketlo-getswe KS, Kraus CK, et al.: The effect of viral suppression on cross-sectional incidence testing in the Johns Hopkins Hospital Emergency Department. J Acquir Immune Defic Syndr 2008;48:211-215.